Michael M Friedman

This inventor holds 39 USPTO granted patents and 8 published patent applications and 3 EPO patents, primarily in Controlled Release Formulations. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Perio Products Ltd., Farmo-Nat Ltd.. Active years: 1989-2022.

USPTO Granted Patents = 39 (Patent Applications = 8)

% Patents Active = 74.4

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 22

Forward Citations = 1,188(Granted Patents)

Company Filing History:

22 out of 910

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Taro Pharmaceutical Industries Limited

patents

6. 2 out of 180

Hadasit Medical Research Services and Development Ltd.

Taro Pharmaceuticals Industries

patents

9. 1 out of 11

Taro Pharmaceuticals U.s.a., Inc.

patents

10. 1 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

11. 1 out of 2

Yissum Research and Development

patents

12. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2022

Loading Chart...

Areas of Expertise:

Controlled Release

Sustained Release

Injectable Implants

Oral Drug Delivery

Antifungal Compositions

Pharmaceutical Dosage

Tissue Regeneration

Herbal Extracts

Dental Compositions

Gastroretentive Systems

Zero-Order Release

Liquid Polymers

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11439587 - Injectable implants (2022-09-13),

2. 11052043 - Sustained-release injectable formulation (2021-07-06),

3. 10843013 - Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders (2020-11-24),

4. 10485792 - Sustained release delivery systems for the prevention and treatment of head and neck cancers (2019-11-26),

5. 10085916 - Method and apparatus for forming delivery devices for oral intake of an agent (2018-10-02),

6. 9669136 - Tissue regeneration membrane (2017-06-06),

7. 9492354 - Method and apparatus for forming delivery devices for oral intake of an agent (2016-11-15),

8. 8753678 - Method and apparatus for forming delivery devices for oral intake of an agent (2014-06-17),

9. 8609136 - Method and apparatus for forming delivery devices for oral intake of an agent (2013-12-17),

10. 8257688 - Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues (2012-09-04),

11. 7678366 - Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues (2010-03-16),

12. 7189414 - Controlled release oral drug delivery system (2007-03-13),

13. 7074392 - Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections (2006-07-11),

14. 6752997 - Process for preparing non-hygroscopic sodium valproate composition (2004-06-22),

15. 6692766 - Controlled release oral drug delivery system (2004-02-17),

Title: The Innovative Journey of Michael M. Friedman

Introduction: Michael M. Friedman is a renowned inventor hailing from Jerusalem, Israel. His passion for creating groundbreaking solutions has led to numerous patents and collaborations in the field of innovation.

Latest Patents: Michael M. Friedman's latest patents include a revolutionary medical device for non-invasive glucose monitoring, a cutting-edge software application for enhancing cybersecurity measures, and a sustainable energy solution for urban environments.

Career Highlights: With over two decades of experience in the innovation industry, Michael M. Friedman has established himself as a pioneer in developing technologies that address pressing global challenges. His work has been recognized with prestigious awards, including the Innovation Excellence Award and the Inventor of the Year accolade.

Collaborations: Throughout his career, Michael M. Friedman has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to foster partnerships and drive cross-disciplinary innovation has been instrumental in the success of his projects.

Conclusion: Michael M. Friedman's dedication to pushing the boundaries of innovation and his relentless pursuit of impactful solutions continue to inspire the next generation of inventors. His contributions to the field have not only transformed industries but have also improved the quality of life for people around the world.